A short-acting label does not guarantee prompt spontaneous awakening in severe hepatic disease.
The report described a patient with advanced cirrhosis undergoing tongue surgery. Clinicians used reduced remimazolam exposure to support circulatory stability, yet flumazenil was still needed for awakening. Consciousness remained clear during subsequent observation.
This was a single patient, not a dose-finding or comparative recovery study. Severe liver disease, body composition, companion drugs and procedure characteristics can contribute. Successful reversal does not establish a universally safe dosing regimen or absence of later risk.
For a delayed-emergence opinion, review total exposure, organ status, clinical observations and reversal timing. Distinguish expected drug elimination from observed functional recovery. The case cautions against applying healthy-volunteer recovery expectations unchanged to a medically complex patient.
Source reviewed: Anesthetic management with remimazolam in a patient with Child Pugh C liver cirrhosis a case report (PMC9792621). Forensic applications above are interpretive analysis of the supplied publication.
Related reading: Awake Intubation in Scoliosis Compared Different Sedative Administration Schedules.